Estimating Glomerular Filtration Rate from Serum Creatinine and Cystatin C
By Lesley A. Inker, Christopher H. Schmid, H. Tighiouart, J. Eckfeldt, Harold I. Feldman, Tom Greene, J. Kusek, J. Manzi, F. van Lente, Y. Zhang and 2 more. New England Journal of Medicine, 2012
3,714 citations recorded by the source corpus.
BACKGROUND Estimates of glomerular filtration rate (GFR) that are based on serum creatinine are routinely used; however, they are imprecise, potentially leading to the overdiagnosis of chronic kidney disease. Cystatin C is an alternative filtration marker for estimating GFR. METHODS Using cross-sectional analyses, we developed estimating equations based on cystatin C alone and in combination with creatinine in diverse populations totaling 5352 participants from 13 studies. These equations were then validated in 1119 participants from 5 different studies in which GFR had been measured. Cystatin and creatinine assays were traceable to primary reference materials. RESULTS Mean measured GFRs were 68 and 70 ml per minute per 1.73 m2 of body-surface area in the development and validation data sets, respectively. In the validation data set, the creatinine–cystatin C equation performed better than equations that used creatinine or cystatin C alone. Bias was similar among the three equations, with a median difference between measured and estimated GFR of 3.9 ml per minute per 1.73 m2 with the combined equation, as compared with 3.7 and 3.4 ml per minute per 1.73 m2 with the creatinine equation and the cystatin C equation (P = 0.07 and P = 0.05), respectively. Precision was improved with the combined equation (inter-quartile range of the difference, 13.4 vs. 15.4 and 16.4 ml per minute per 1.73 m2, respectively [P = 0.001 and P<0.001]), and the results were more accurate (percentage of estimates that were >30% of measured GFR, 8.5 vs. 12.8 and 14.1, respectively [P<0.001 for both comparisons]). In participants whose estimated GFR based on creatinine was 45 to 74 ml per minute per 1.73 m2, the combined equation improved the classification of measured GFR as either less than 60 ml per minute per 1.73 m2 or greater than or equal to 60 ml per minute per 1.73 m2 (net reclassification index, 19.4% [P<0.001]) and correctly reclassified 16.9% of those with an estimated GFR of 45 to 59 ml per minute per 1.73 m2 as having a GFR of 60 ml or higher per minute per 1.73 m2. CONCLUSIONS The combined creatinine–cystatin C equation performed better than equations based on either of these markers alone and may be useful as a confirmatory test for chronic kidney disease. (Funded by the National Institute of Diabetes and Digestive and Kidney Diseases.)
Subfields: Nephrology
View Paper: https://www.semanticscholar.org/paper/864b8e44b48f701b2cf2f7609bfcb54c52d74233
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Nephrology
- M. Bernardi
- Aleksander Krag
- Harold I. Feldman
- C. Francoz
- C. Villanueva
- B. Astor
- J. Trebicka
- W. Laleman
Citations in the corpus
- The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases (2018, background): “, with the creatinine-cystatin C equation) is more accurate than estimates of renal function that are derived from serum creatinine alone.((254))”
- EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis. (2018, background): “When only based on reduction of GFR, the diagnosis of CKD in patients with cirrhosis is still challenging, because all the SCr-based equations that have been proposed overestimate GFR in patients with cirrhosis [300-304].”
- KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD. (2014, methodology): “The specific goals of the KDIGO CKD guideline update were to clarify the definition and classification system of CKD and to develop appropriate guidance for themanagement of individuals with CKD.2 The primary recommendations were to retain KDOQI’s use of GFR as the principal basis for staging CKD, b”